Skip to main content

Genetic Technologies embraces global vision for genomic-integrated healthcare

Genetic Technologies Ltd (ASX:GTG) CEO Simon Morriss is back with Proactive’s Elisha Newell to outline the company’s latest endeavours in the predictive genetics space. Lauded as a pioneer in clinical genetics tech, GTG is working on early-stage tools that help clinicians and patients proactively manage their health. Morriss says the company’s product suite is geared towards personalised, non-invasive testing and risk assessments, all designed to accelerate a global transition to genomic-integrated healthcare.

Contact Details

Proactive Investors

Jonathan Jackson

+61 413 713 744

jonathan@proactiveinvestors.com

Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.